Find Academic Supervisors

Federica Tomao is an Associate Professor at the Department of Maternal, Child and Urological Sciences within Sapienza University of Rome. She actively teaches and supervises courses in Medicine and Surgery , Nursing , and Midwifery programs across multiple institutions. Current faculty member with academic rank Teaching roles in 6th, 3rd, and 2nd year courses Specialized in gynecologic oncology Research Focus : Her work spans ovarian cancer, breast cancer, and endometrial cancer, emphasizing chemotherapy optimization, precision medicine, and radiomics. Notably, she contributes to understanding PARP inhibitors, immune checkpoint therapies, and fertility preservation techniques in cancer survivors. Recent Publications highlight advancements in sarcopenia analysis, BRCA testing, and radiogenomic nomograms. These studies demonstrate her commitment to bridging imaging and molecular data for improved cancer management. Email : federica.tomao@uniroma1.it

• Gynecologic Oncology
• Ovarian Cancer
• Breast Cancer
• +5 more

Andrea Falini is a Full Professor of Neuroradiology at the Vita-Salute San Raffaele University (School of Medicine). He holds leadership roles including Head of the Neuroradiology Department at the Scientific Institute S. Raffaele Hospital and Head of the Advanced Diagnostic in Neuro-oncology Unit. His career spans clinical, academic, and administrative roles since 1991, with extensive experience in neuroradiology, neuro-oncology, and neuroimaging research. Education: MD (1986, University of Milan), PhD in Neurological Sciences (1989), and specialized training in Neurology and Radiology at leading institutions, including a visiting scholar position at UCSF (1996). Research interests focus on advanced MRI techniques, neuro-oncology, neurodegenerative diseases, and cognitive neuroscience. His work emphasizes functional MRI, diffusion tensor imaging, and clinical applications in glioma management and neurodegenerative disorders. Awarded the 1989 'De Visart' Prize and grants supporting his international collaborations. He has authored 218+ peer-reviewed articles, with an H-index of 40+, and actively contributes to academic committees and international conferences. Leadership roles include Vice-Director of the Neuroscience Division (2014–present) and coordination of the BraiMap Research Program. His academic teaching spans neuroradiology, biomedical engineering, and cognitive neuroscience courses.

• Advanced MR Techniques
• Neuro-oncology
• Degenerative Diseases
• +3 more

Della F. Makower, M.D. is an Oncology specialist at Montefiore Medical Center with a robust research portfolio focusing on breast cancer treatment, chemotherapy effects, and health disparities. With 49 publications and an h-index of 21, she has made significant contributions to understanding cancer treatment outcomes, particularly regarding social determinants of health and racial disparities in cancer care. Her research interests span multiple critical areas in oncology including: Breast Cancer (100% research focus) Chemotherapy (76% research focus) Recurrent Disease (61% research focus) Malignant Neoplasm (44% research focus) Endocrine Therapy (30% research focus) Hormone Receptor research (25% research focus) Dr. Makower's recent publications demonstrate a strong emphasis on health equity, with multiple studies examining racial disparities in cardiotoxicity, the impact of social determinants on cancer treatment outcomes, and specialized research on breast cancer in diverse patient populations. Her work frequently appears in high-impact journals including the Journal of the American Heart Association, Breast Cancer Research and Treatment, Cancer, and the Journal of Clinical Oncology. Notable research initiatives include: ECOG-ACRIN EA1131 trial comparing adjuvant platinum versus capecitabine for triple-negative breast cancer ECOG-ACRIN EAZ171 trial investigating germline predictors of taxane-induced neuropathy in Black women with breast cancer Studies examining the relationship between social determinants of health and anthracycline cardiotoxicity Research on the impact of the COVID-19 pandemic on breast cancer screening and diagnosis Her collaborative approach is evident in the multi-institutional nature of her research, with frequent collaborations across major cancer research networks. Dr. Makower's work has garnered significant attention, with multiple studies picked up by news outlets and discussed on social media platforms including X (Twitter) and Facebook.

• Breast Cancer
• Chemotherapy
• Pharmacology
• +7 more

Prof.ssa Elda Favari is a Full-Time Associate Professor of Pharmacology at the Department of Food and Drug, University of Parma, Italy . Her research focuses on atherosclerosis physiology , cholesterol metabolism , and cellular cholesterol efflux processes . She has collaborated with international institutions in the USA , Australia , and Switzerland . PhD in Pharmacology and Toxicology (University of Parma, 2005) Academic Editor for the journal Medicine Member of Italian Society of Pharmacology , European Lipoprotein Club , and International Atherosclerosis Society Her scientific contributions include over 50 peer-reviewed publications , an H-index of 23 , and 16 Q1-journal publications from the last 15 years. Key research areas cover reverse cholesterol transport , PCSK9 mechanisms , and HDL functionality in diseases like familial hypercholesterolemia , cancer , and autoimmune disorders . Recent Google Scholar publications (2023-2025) examine: HDL modulation through nutraceuticals and 3D-printed devices Immune checkpoint inhibitors in relation to lipid profiles PCSK9-lomitapide interactions in genetic lipid disorders Anti-ApoA-1 IgGs as atherogenic factors 2000: AstraZeneca Grant at SISA Congress 2011: National Research Grant for Lupus Study She has held institutional roles including Student Orientation Delegate and serves on scientific committees for international congresses. Teaching spans Toxicology , Anticancer Chemotherapy , and Pharmacovigilance across Pharmacy , Food Safety , and Drug Sciences programs.

• Pharmacology
• Toxicology
• Atherosclerosis
• +3 more

Pier Giorgio Petronini is a Full Professor of General Pathology at the University of Parma, leading the Experimental Oncology Laboratory within the Department of Medicine and Surgery. He has held research positions at the Pasteur Institute in Paris and serves on the Novartis Oncology Advisory Board, as Academic Editor for PLOS ONE, and reviewer for multiple journals. Scientific Director of Chiara Tassoni Association for Leukemia Research and Augusto per la Vita Association Member of Italian Society of Cancerology, European Association for Cancer Research, and American Society for Investigative Pathology His research focuses on translational molecular oncology in lung, breast cancer, and malignant pleural mesothelioma, emphasizing preclinical therapeutic strategies. Key projects include targeting CDK4/6, EGFR, and PD-L1 pathways, with recent work on metabolic adaptations in drug-resistant cancers. Selected publications highlight advancements in: CDK4/6-PI3K/AKT/mTOR combination therapy for TNBC FGFR2-MEK synergy in cancers of unknown primary PD-L1-STAT signaling in NSCLC angiogenesis He coordinates grants from AIRC, Novartis, AstraZeneca, and Chiesi Farmaceutici, and holds patents for irreversible EGFR and MDR1 inhibitors.

• Translational Molecular Oncology
• Lung Cancer
• Breast Cancer
• +1 more

Marco Pelin is an Associate Professor at the University of Trieste's Department of Life Sciences, where he serves in multiple leadership roles including Member of the Department's Board, Doctoral Studies Boards, and as Delegate for Outgoing Orientation. He is a key researcher in the 'Pharmacology and Toxicology of Natural Substances' group, focusing on biomedicine and pharmacology/chemotherapy research strands. His research examines: Risk characterization of algal biotoxins and detection methods Toxicological mechanisms of marine toxins (palytoxins, azaspiracids) Nanomaterial safety assessments (graphene toxicity) Ecotoxicological impacts using Artemia franciscana models Publication analysis reveals two primary research arcs: marine toxin toxicology (detection methods, mechanisms, risk assessment) and nanomaterial safety (cutaneous exposure risks, biocompatibility evaluations). His work consistently employs cellular models and develops analytical techniques for environmental monitoring. Active research grants include: Principal Investigator: 'Tox-IT' (Emerging toxins in Italian seas) Scientific lead: 'Safe2energy' (2D material lifecycle safety) Contributor: 'STOPTTXs' (Tetrodotoxin risk mitigation) He collaborates in the Pharmacology and Toxicology research group with Prof. Aurelia Tubaro, supervising technical staff and PhD candidates while utilizing cellular and ecotoxicological laboratory models.

• Pharmacology
• Toxicology
• Nanotoxicology
• +3 more

Francesca Ieva serves as Associate Head of the Health Data Science Centre at Human Technopole and Associate Professor of Statistics at the Politecnico di Milano, where she leads the MOX - Modeling and Scientific Computing laboratory within the Department of Mathematics. She also co-leads the Di Angelantonio & Ieva Group, a collaborative research team focused on integrating molecular data with clinical information to advance precision medicine. Dr. Ieva received her PhD in Mathematical Models and Methods for Engineering in 2012. Her academic journey has positioned her at the forefront of health data science, bridging statistical methodology with biomedical applications. Her research focuses on statistical learning in biomedical sciences, with particular emphasis on developing advanced models for integrating complex clinical data to inform predictions in clinical decision-making. Francesca's work spans multiple domains including: Development of novel survival analysis techniques for healthcare applications Integration of DNA methylation data for cardiovascular risk prediction Application of machine learning to clinical pathway analysis in mental health Innovative approaches to polygenic risk scoring incorporating SNP interactions Development of radiomics models for cancer prognosis and treatment response Analysis of Dr. Ieva's recent publications reveals a strong trend toward federated learning approaches in healthcare data analysis, reflecting growing concerns about data privacy while maintaining analytical power. Her work increasingly integrates multiple data types (genomic, epigenetic, imaging, and clinical records) to create more comprehensive patient profiles for precision medicine applications. A notable pattern is her focus on translating complex statistical models into clinically actionable tools that can directly inform patient care and healthcare policy decisions. As Associate Head of the Health Data Science Centre at Human Technopole, Dr. Ieva oversees a research group comprising epidemiologists, statisticians, and data scientists working collaboratively to bridge the gap between genotype and phenotype. The Di Angelantonio & Ieva Group develops innovative studies that integrate biomolecular data with medical records, imaging, and portable medical device data. Her team utilizes both existing healthcare data and newly generated population-based studies, applying novel analytical methods that integrate clinical epidemiology with health research to improve data interpretation. Dr. Ieva actively mentors several PhD students including Andrea Lampis, Katherine Marie Logan, Alessia Mapelli, Michela Carlotta Massi, and Andrea Mario Vergani. Her research has been supported by collaborations with major healthcare institutions and likely receives funding from research councils and health technology initiatives, though specific grant details are not provided in the available information.

• Biostatistics
• Health Data Science
• Statistical Learning
• +5 more

Bianca Papotti is a fixed-term Researcher at the Department of Food and Pharmaceutical Sciences, University of Parma. Her academic career spans interdisciplinary research in Pharmacology Cholesterol Metabolism Neurodegenerative Diseases Cardiovascular Pathology Immunometabolism . She teaches courses including Experimental Pharmacology and Food Toxicology. Her research focuses on the role of PCSK9 and cholesterol efflux in Alzheimer's Disease Atherosclerosis Rheumatoid Arthritis Lipoprotein Biology Inflammatory Disease Drug Development . Key trends in her publications (3 in 2025, 12 in 2024) reveal strong emphasis on PCSK9 inhibition mechanisms, cholesterol-immune crosstalk in rheumatoid arthritis, and fasting interventions in lipid-related pathologies. Her work has explored PCSK9's neuroinflammatory effects ABCA1/ABCG1 transporter dynamics Macrophage cholesterol loading Natural compound screening HDL dysfunction in diabetes Covid-19 lipid interactions .

• Pharmacology
• Cholesterol Metabolism
• Alzheimer's Disease
• +5 more

Prof. Umberto Lucia , Full Professor of Thermal Physics at the Politecnico di Torino 's Department of Energy (DENERG), is a leading expert in Non-Equilibrium Thermodynamics , Biophysics , and Quantum Thermodynamics . His work bridges Industrial Engineering with Biomedical Applications , focusing on entropy production, structural irreversibility, and thermodynamic modeling of biological systems. Education: PhD in Energetics (1995, University of Florence), MSc in Physics of Matter (1997, University of Ferrara), MSc in Experimental Nuclear Physics (1991, University of Turin) His research interests span: Thermodynamic analysis of cancer growth via exergetic and Constructal Law approaches Magnetocaloric refrigeration for sustainable technologies Quantum thermodynamics in open atomic systems Transport phenomena in biological membranes Thermoeconomic indicators for sustainability (THDI index) Photofission and nuclear energy systems Recent publications highlight his work on biomethane production from rice straw , low-frequency EMF effects on tumors , and thermodynamic time definitions , reflecting interdisciplinary trends in Energy Systems , Quantum Biology , and Sustainable Policy . Scientific awards include Constructal Law Prize (2024) Siebel Energy Institute Smart Energy Award (2015) Fellowships at Constructal Law Conferences (2012-2019) Advising and grants feature PhD student Giulia Grisolia. He leads projects like ELF (EMF cancer inhibition), PlaSNeuriM (neurorehabilitation), and ReVideo (visual rehabilitation), with patents on magnetic cancer therapy and neurorehabilitation insoles . Labs: PolitoBIOMed Lab (Biomedical Engineering), Energy Center Lab, and INFN (National Institute for Nuclear Physics) collaborations.

• Thermodynamics
• Biophysics
• Quantum Physics
• +5 more

Dr. Silvio Sosa is an Associate Professor in the Department of Pharmacology at the Department of Life Sciences, University of Trieste. He serves on the Department's Board and is an active member of the Pharmacology and toxicology of natural substances research group led by Professor Aurelia Tubaro. His academic position places him within the Biomedicine research area and Pharmacology and chemotherapy research strand at the university. His research interests include: Pharmacology and toxicology of marine biotoxins, particularly palytoxins and TTXs (Tetrodotoxins) Development of detection methods for algal toxins in seafood Toxicological investigation of graphene and graphene-based nanomaterials Risk assessment of emerging toxins in marine environments Cutaneous toxicity of nanomaterials Food safety monitoring for marine toxin contamination Dr. Sosa's recent publications reveal a strong focus on marine toxin mechanisms and nanomaterial safety. His work spans from fundamental toxicology studies on pinnatoxin G and azaspiracids to practical applications in detection methods and risk assessment. A significant portion of his research addresses the Mediterranean-specific issue of Ostreopsis blooms and associated toxins, with implications for both public health and local economies dependent on coastal tourism and seafood industries. His scientific contributions include awards and recognition through active participation in major research projects funded by Italian Ministry of Health, Ministry of University and Research, and INAIL. These projects address critical issues in marine toxin safety and nanomaterial applications. Dr. Sosa maintains an active research program with ongoing investigations into the toxicological profiles of emerging marine toxins and the safety assessment of graphene-based materials. His work bridges laboratory research with practical applications for public health protection, particularly in coastal regions where marine toxin exposure poses significant risks to human health and local economies.

• Pharmacology
• Toxicology
• Marine Toxins
• +3 more

Patrizia Proia is an Associate Professor at the University of Palermo, Department of Psychological, Pedagogical, Physical Exercise and Training Sciences. Her research focuses on exercise physiology, sports genetics, and neurobiological mechanisms linked to physical activity. She teaches courses in biochemistry, physiology of nutrition, and sports training adaptation. Current research on microbiome-exercise interactions Developing protocols for MS and Parkinson's rehabilitation Investigating genetic polymorphisms in elite athletes Exploring nutrigenomics and functional foods Recent publications analyze: Muscle regeneration through probiotic supplementation Impact of nanotechnological devices on pain management Epigenetic regulation of executive functions Bone health in gymnasts and cancer patients Role of gut microbiome in exercise response

• Exercise Physiology
• Sports Nutrition
• Genetic Polymorphisms in Athletes
• +6 more

Silvia Giordano is a Professor at the Department of Oncology, University of Turin. Her research focuses on oncology, molecular medicine, and cancer biology, with particular emphasis on gastric cancer, targeted therapies, and drug development. She contributes to courses like Basis of Human Morphology and Molecular bases of targeted therapies. Giordano leads studies on tumor cell signaling, resistance mechanisms, and translational models, including patient-derived xenograft (PDX) collections. She collaborates with institutions like the IRCCS Candiolo Cancer Institute and serves on academic bodies such as the Department Council. Her work bridges basic research and clinical applications, addressing challenges in cancer treatment and drug resistance. She has published extensively on topics like MET receptor biology, hepatocellular carcinoma models, and synergistic chemotherapy combinations.

• Oncology
• Molecular Medicine
• Cancer Biology
• +5 more

Stefania D'Onofrio holds a full-time permanent position as a 1st-level Physicist Manager at AUSL Latina, Italy. She is affiliated with the University of Rome “La Sapienza,” where she has held teaching roles in courses such as ‘Fisica applicata alla strumentazione radiodiagnostica e radioterapia’ and ‘Fisica applicata’ for diagnostic health technical programs. Her current role involves managing medical physics activities, including radiation therapy planning and clinical dosimetry. She completed her Laurea in Physics (summa cum laude) in 2000 and a specialization in Medical Physics in 2003, both from Sapienza University. Her research focuses on radiation dosimetry, Monte Carlo simulations, and clinical applications in oncology. She has presented extensively at national congresses, including works on brachytherapy, stereotactic radiotherapy, and radiation-induced cardiac effects. Education: Laurea in Physics - University of Rome “La Sapienza” (2000, 101/110) Specialization in Medical Physics - University of Rome “La Sapienza” (2003, 48/50) Research Interests: Medical Physics applications in radiation therapy Monte Carlo simulations for dosimetry Radiochromic film dosimetry Image fusion in radiation oncology Radiation-induced side effects Stereotactic radiosurgery dosimetry Her articles emphasize advancements in dosimetric techniques and clinical outcomes of radiotherapy protocols, particularly in breast cancer, gliomas, and head-and-neck cancers. She has contributed to over 10 peer-reviewed studies and conference proceedings. Her work integrates experimental and computational methods to improve precision in radiation treatment planning. Advising & Grants: Supervised two theses in Medical Physics (details not disclosed) Active in clinical research at AUSL Latina’s Medical Physics Complex Structure Labs/Teams: Core member of the Struttura Complessa di Fisica Medica at AUSL Latina, collaborating on radiation therapy protocols and diagnostic imaging integration.

• Medical Physics
• Radiation Therapy
• Dosimetry
• +3 more

Patrizia Santi is a Full Professor at the Department of Pharmaceutics, Faculty of Pharmacy, University of Parma. She has served as Vice-Dean of the Faculty of Pharmacy since 2010 and has held teaching appointments in Pharmaceutical Technology, Cosmetic Products, and Pharmaceutical Formulation since 1998. Her international experience includes roles at the University of Lille and University of California, San Francisco. PhD, Pharmaceutical Chemistry and Technology (1992), University of Parma PharmD, Chemistry and Pharmaceutical Technology (1987), University of Parma Her research focuses on controlled drug delivery systems , particularly transdermal, ocular, and buccal routes using iontophoresis, microneedles, and bioadhesive films. She has contributed to polymeric micelles, crosslinked hydrogels, and ocular transport mechanisms. Her recent publications highlight ocular delivery of neuroprotective compounds , transscleral iontophoresis , microneedle-assisted buccal delivery , and bioadhesive films for local anesthetics . She also explores archaeometric provenance studies for historical materials. Scientific Awards & Memberships ERASMUS Fellowship (1988-1989) A.F.I.-T.R.F. PHARMA WORKS award (1992) Board of Scientific Advisor, Controlled Release Society (CRS, 2001-2004) Professional Activities Advisor for 6 PhD students in Biopharmaceutics-Pharmacokinetics Member of AAPS, CRS, ADRITELF, APGI societies Teaching: Cosmetic Products , Drug Release and Targeting , Quality Assurance in Higher Education Co-authored 92 journal papers, 5 book chapters, 10 patents, and 170 conference communications

• Controlled Drug Delivery
• Pharmaceutical Chemistry
• Transdermal Delivery of Drugs and Cosmetics
• +3 more

Sabrina Pacor is an Associate Professor in Applied Biology (BIO/13) at the University of Trieste , where she teaches Pharmacology in the Pharmacy LM and STB BSc programs. With over 30 years of research experience in experimental oncology and host defense peptides, she has made significant contributions to studying antimicrobial peptides (AMPs) and their interactions with bacterial membranes. Her research focuses on: Direct antimicrobial activity of AMPs against Gram-positive and Gram-negative bacteria Indirect immunomodulatory effects of host defense peptides Development of drug delivery systems using nanomaterials (carbon nanotubes, gold nanoparticles) Mechanistic studies of ruthenium-based antimetastatic drugs She leads extensive cytofluorimetry research using flow cytometry platforms, particularly for evaluating: Cytotoxicity (necrosis/apoptosis, proliferation index) Modulation of host biological responses (chemotaxis, phagocytosis, ROS production) Peptide-bacterial membrane interactions through fluorescent labeling Her recent work demonstrates trends in: Proline-rich antimicrobial peptides against ESKAPE pathogens Hybrid antibiotic design (peptide-aminoglycoside conjugates) Structure-activity relationships in membranolytic peptides Evolutionary insights into defensin and cathelicidin families Prof. Pacor has co-authored over 100 peer-reviewed publications and actively mentors students, having supervised: 70 experimental/thesis reviews for Pharmacy/CTF Master's students 20 Bachelor's degree theses

• Pharmacology
• Chemotherapy
• Cytofluorimetry
• +3 more